Literature DB >> 2529426

Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: effects of protein sequence and intracellular environment.

O Halevy1, A Hall, M Oren.   

Abstract

The transformation-related protein p53 is normally very labile. The stability of p53 is significantly increased in a number of fibrosarcoma cell lines derived from mouse tumors induced by treatment with physical or chemical agents. In many instances, p53 stabilization is correlated with the ability to form a stable complex with the heat shock protein cognate hsc70. We describe a line in which p53 is very stable yet has no detectable interaction with hsc70. The inability to form such a complex probably resides in the primary structure of the endogenous p53, since introduction of other p53 variants into those cells resulted in the appearance of a p53-hsc70 complex. The factors affecting p53 stability were investigated by stable transfection experiments. The results indicated that the primary structure of the p53 protein is a major determinant of its turnover rate; different p53 variants were degraded at distinct and characteristic rates in a number of transformed cell types. However, at least one p53 variant was degraded differently in nontransformed BALB/c-3T3 than in transformed fibrosarcoma cells, demonstrating that the specific cellular environment can also affect the stability of p53.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529426      PMCID: PMC362384          DOI: 10.1128/mcb.9.8.3385-3392.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Meth A fibrosarcoma cells express two transforming mutant p53 species.

Authors:  D Eliyahu; N Goldfinger; O Pinhasi-Kimhi; G Shaulsky; Y Skurnik; N Arai; V Rotter; M Oren
Journal:  Oncogene       Date:  1988-09       Impact factor: 9.867

2.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.

Authors:  D Eliyahu; A Raz; P Gruss; D Givol; M Oren
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

3.  Energy requirement for degradation of tumor-associated protein p53.

Authors:  R M Gronostajski; A L Goldberg; A B Pardee
Journal:  Mol Cell Biol       Date:  1984-03       Impact factor: 4.272

Review 4.  The 53,000-dalton cellular protein and its role in transformation.

Authors:  L Crawford
Journal:  Int Rev Exp Pathol       Date:  1983

5.  Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

Authors:  D Wolf; N Harris; V Rotter
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

6.  A single gene and a pseudogene for the cellular tumour antigen p53.

Authors:  R Zakut-Houri; M Oren; B Bienz; V Lavie; S Hazum; D Givol
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

7.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.

Authors:  J R Jenkins; K Rudge; G A Currie
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

8.  Expression of the mouse p53 cellular tumor antigen in monkey cells.

Authors:  O Pinhasi; M Oren
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

9.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

Authors:  L F Parada; H Land; R A Weinberg; D Wolf; V Rotter
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

10.  Analysis of the gene coding for the murine cellular tumour antigen p53.

Authors:  B Bienz; R Zakut-Houri; D Givol; M Oren
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more
  17 in total

1.  Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.

Authors:  E Shaulian; A Zauberman; D Ginsberg; M Oren
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Transformed and nontransformed cells differ in stability and cell cycle regulation of a binding activity to the murine thymidine kinase promoter.

Authors:  D W Bradley; Q P Dou; J L Fridovich-Keil; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.

Authors:  D Ronen; Y Teitz; N Goldfinger; V Rotter
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

4.  Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding.

Authors:  D Michael-Michalovitz; F Yehiely; E Gottlieb; M Oren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein.

Authors:  D Ginsberg; D Michael-Michalovitz; D Ginsberg; M Oren
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

6.  Prolonged nuclear accumulation of p53 in xeroderma pigmentosum complementation group A cells after ultraviolet irradiation.

Authors:  S Kato; Y Urano; S Sasaki; K Ahsan; M Shono; S Arase
Journal:  Arch Dermatol Res       Date:  1996-05       Impact factor: 3.017

7.  High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma.

Authors:  E Cesarman; G Inghirami; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

8.  The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.

Authors:  L Duan; I Ozaki; J W Oakes; J P Taylor; K Khalili; R J Pomerantz
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences.

Authors:  F Tiemann; W Deppert
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas.

Authors:  E Latres; M Drobnjak; D Pollack; M R Oliva; M Ramos; M Karpeh; J M Woodruff; C Cordon-Cardo
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.